AHPA Recommends FDA Implement Policies to Support Responsible Innovation
The American Herbal Products Association (AHPA) submitted extensive and specific policy recommendations on July 15 to the [...]
Federal Register
FDA to Hold Public Meeting on Responsible Innovation in Dietary Supplements
The U.S. Food and Drug Administration (FDA) recently announced a May 16 public meeting entitled “Responsible Innovation in [...]
Efficient Regulatory Structure Critical to Protecting Consumers and Public Health, says NPA
The Natural Products Association (NPA) has called for a streamlined and efficient regulatory structure to protect consumers [...]
UNPA Announces No-sale Policy for Liquid, High-dose Caffeine Products as a Condition of Membership
The United Natural Products Alliance (UNPA) has approved the adoption of a new, “no-sale” policy for liquid, [...]
AHPA Submits Vinpocetine Comments to FDA
The American Herbal Products Association (AHPA) recommends the Secretary of Health and Human Services (HHS) consider [...]
NPA Supports Lawful Marketing of Vinpocetine
The Natural Products Association (NPA) has submitted comments to the U.S. Food and Drug Administration (FDA) in response to [...]
FDA Considering Vinpocetine Ineligible as a Dietary Ingredient
The U.S. Food and Drug Administration (FDA) recently released an unprecedented Federal Register (FR) notice (Docket No: [...]
Industry Urges FDA to Define “Natural”
The American Herbal Products Association (AHPA) submitted comments to the U.S. Food and Drug Administration (FDA) [...]